<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>CytoCares | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-29T20:24:15+08:00</updated>
  <subtitle>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>GAS6/TAM 信号通路：值得期待的下一代肿瘤治疗靶点</title>
    <updated>2020-12-29T19:16:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/ipb6ByjDsov21NEYjCIzxA</id>
    <link href="https://mp.weixin.qq.com/s/ipb6ByjDsov21NEYjCIzxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“变节”的NK细胞：蜕膜样NK细胞极化</title>
    <updated>2020-12-25T19:03:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/1o8qENYYl0g-J6rHZJUMoQ</id>
    <link href="https://mp.weixin.qq.com/s/1o8qENYYl0g-J6rHZJUMoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>儿童罕见高危神经母细胞瘤：GD2单抗大显身手</title>
    <updated>2020-12-24T18:33:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/AqAose2CqOGpRPt71in6aw</id>
    <link href="https://mp.weixin.qq.com/s/AqAose2CqOGpRPt71in6aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制约CAR-T产品上市，药学评价是关键一环！</title>
    <updated>2020-12-23T18:24:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/6sl49i0mm5gRGuE5eKxW-g</id>
    <link href="https://mp.weixin.qq.com/s/6sl49i0mm5gRGuE5eKxW-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-12月24日</title>
    <updated>2020-12-23T18:24:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/xItjhpsw1UL5dpZA21LnAg</id>
    <link href="https://mp.weixin.qq.com/s/xItjhpsw1UL5dpZA21LnAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>自免新方向：CD25偏向性IL2结合抗体有效呈递激活Treg细胞</title>
    <updated>2020-12-22T18:06:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/z7fFCE-tHI_rwKtTPHLsOw</id>
    <link href="https://mp.weixin.qq.com/s/z7fFCE-tHI_rwKtTPHLsOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-12月22日</title>
    <updated>2020-12-22T18:06:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/mv38eOnG_Tr8uid9fkyGew</id>
    <link href="https://mp.weixin.qq.com/s/mv38eOnG_Tr8uid9fkyGew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>北京市卫健委正式发布《CAR-T细胞免疫疗法临床研究伦理审查指南》</title>
    <updated>2020-12-17T17:39:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/MDyvYvmyjhPoz-WtffdnjQ</id>
    <link href="https://mp.weixin.qq.com/s/MDyvYvmyjhPoz-WtffdnjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点2020上市的抗体新药-naxitamab</title>
    <updated>2020-12-15T18:58:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/-kU6Me-LwedgGe5lbTBtkQ</id>
    <link href="https://mp.weixin.qq.com/s/-kU6Me-LwedgGe5lbTBtkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-12月15日</title>
    <updated>2020-12-15T18:58:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/oDywV_Abi5hkGyfnopsfBg</id>
    <link href="https://mp.weixin.qq.com/s/oDywV_Abi5hkGyfnopsfBg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GITR激动剂单药尽数惨败，MEDI1873停止临床研究！</title>
    <updated>2020-12-14T19:05:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/fATZK6Udpwu4VhCyn3VAIA</id>
    <link href="https://mp.weixin.qq.com/s/fATZK6Udpwu4VhCyn3VAIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-12月11日</title>
    <updated>2020-12-11T19:54:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/c1bgfR4nAoFdcbIIkZiuZg</id>
    <link href="https://mp.weixin.qq.com/s/c1bgfR4nAoFdcbIIkZiuZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>两例经过CART治疗的患者完全缓解！MacroGenics公布Tebotelimab（PD-1 × LAG-3）初步临床数据</title>
    <updated>2020-12-10T19:05:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/wi_qqS_iebVxYKXknWMEiA</id>
    <link href="https://mp.weixin.qq.com/s/wi_qqS_iebVxYKXknWMEiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>